Get started
Abbott LaboratoriesAbbott LaboratoriesAbbott Laboratories

Abbott Laboratories

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

ABT chart


Full chart

Key facts today

Abbott Laboratories won a Missouri court case over baby formulas, boosting shares by 5.4% to $119.50. Analysts suggest this victory may lower total liabilities by $500 million to $1 billion.
Analyze the impactAnalyze the impact

ABT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪205.71 B‬USD
Dividend yield (indicated)
1.94%
Price to earnings Ratio (TTM)
34.48
Basic EPS (TTM)
3.30USD
Net income (FY)
‪5.70 B‬USD
Revenue (FY)
‪40.11 B‬USD
Shares float
‪1.73 B‬
Beta (1Y)
0.29

Employees


Employees (FY)
‪114 K‬
Change (1Y)
‪−1 K‬ −0.87%
Revenue / Employee (1Y)
‪351.83 K‬USD
Net income / Employee (1Y)
‪50.01 K‬USD

About Abbott Laboratories


Sector
Health Technology
Industry
Medical Specialties
CEO
Robert B. Ford
Website
abbott.com
Headquarters
Abbott Park
Founded
1888
FIGI
BBG000B9ZXB4
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

ABT news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ABT highest yielding bonds


S
ABT3985539
St. Jude Medical, LLC 4.75% 15-APR-2043
Yield to maturity
6.61%
Maturity date
Apr 15, 2043
US2824BH2
ABBOTT LABS 16/46
Yield to maturity
5.24%
Maturity date
Nov 30, 2046
ABT4466215
Abbott Laboratories 4.75% 15-APR-2043
Yield to maturity
5.12%
Maturity date
Apr 15, 2043
ABT.GX
Abbott Laboratories 6.0% 01-APR-2039
Yield to maturity
5.12%
Maturity date
Apr 1, 2039
ABT.HB
Abbott Laboratories 5.3% 27-MAY-2040
Yield to maturity
5.10%
Maturity date
May 27, 2040
ABT.GW
Abbott Laboratories 6.15% 30-NOV-2037
Yield to maturity
5.09%
Maturity date
Nov 30, 2037
ABLC
ABBOTT LABS 16/36
Yield to maturity
5.02%
Maturity date
Nov 30, 2036
S
ABT4289257
St. Jude Medical, LLC 3.875% 15-SEP-2025
Yield to maturity
4.59%
Maturity date
Sep 15, 2025
US2824BQ2
ABBOTT LAB 20/30
Yield to maturity
4.44%
Maturity date
Jun 30, 2030
US2824BF6
ABBOTT LABS 16/26
Yield to maturity
4.40%
Maturity date
Nov 30, 2026
ABT5005071
Abbott Laboratories 1.15% 30-JAN-2028
Yield to maturity
4.33%
Maturity date
Jan 30, 2028

Explore more bonds 

Sparks


Curated watchlists where ABT is featured.

See all sparks 

Frequently Asked Questions


The current price of ABT is 118.60 USD — it has increased by 5.42% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Abbott Laboratories stocks are traded under the ticker ABT.
ABT stock has risen by 2.90% compared to the previous week, the month change is a 5.41% rise, over the last year Abbott Laboratories has showed a 24.87% increase.
We've gathered analysts' opinions on Abbott Laboratories future price: according to them, ABT price has a max estimate of 146.00 USD and a min estimate of 117.00 USD. Watch ABT chart and read a more detailed Abbott Laboratories stock forecast: see what analysts think of Abbott Laboratories and suggest that you do with its stocks.
ABT reached its all-time high on Dec 27, 2021 with the price of 142.60 USD, and its all-time low was 0.11 USD and was reached on Oct 4, 1974. View more price dynamics on ABT chart.
See other stocks reaching their highest and lowest prices.
ABT stock is 5.59% volatile and has beta coefficient of 0.29. Track Abbott Laboratories stock price on the chart and check out the list of the most volatile stocks — is Abbott Laboratories there?
Today Abbott Laboratories has the market capitalization of ‪197.25 B‬, it has decreased by −1.79% over the last week.
Yes, you can track Abbott Laboratories financials in yearly and quarterly reports right on TradingView.
Abbott Laboratories is going to release the next earnings report on Jan 22, 2025. Keep track of upcoming events with our Earnings Calendar.
ABT earnings for the last quarter are 1.21 USD per share, whereas the estimation was 1.20 USD resulting in a 0.65% surprise. The estimated earnings for the next quarter are 1.34 USD per share. See more details about Abbott Laboratories earnings.
Abbott Laboratories revenue for the last quarter amounts to ‪10.63 B‬ USD, despite the estimated figure of ‪10.55 B‬ USD. In the next quarter, revenue is expected to reach ‪11.04 B‬ USD.
ABT net income for the last quarter is ‪1.64 B‬ USD, while the quarter before that showed ‪1.30 B‬ USD of net income which accounts for 26.45% change. Track more Abbott Laboratories financial stats to get the full picture.
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.55 USD. As of today, Dividend Yield (TTM)% is 1.94%. Tracking Abbott Laboratories dividends might help you take more informed decisions.
Abbott Laboratories dividend yield was 1.89% in 2023, and payout ratio reached 63.81%. The year before the numbers were 1.75% and 49.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 2, 2024, the company has ‪114.00 K‬ employees. See our rating of the largest employees — is Abbott Laboratories on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Abbott Laboratories EBITDA is ‪9.98 B‬ USD, and current EBITDA margin is 24.13%. See more stats in Abbott Laboratories financial statements.
Like other stocks, ABT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abbott Laboratories stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Abbott Laboratories technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Abbott Laboratories stock shows the strong buy signal. See more of Abbott Laboratories technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.